MIR100HG

Across TCGA pan-cancer cohorts, MIR100HG RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated MIR100HG data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher MIR100HG RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR100HG expression acts as an unfavorable survival marker, although some lineages such as UCS and LIHC show a favorable association.

KIRP, UCS, and BLCA are the cancer types where MIR100HG RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	DFS	Median	All	0.432	0.809	<.001	123	view →
UCS	OS	Median	II,III,IV	0.709	0.265	<.001	108	view →
BLCA	OS	Median	All	0.350	0.498	<.001	76	view →
LIHC	OS	Median	All	0.765	0.613	<.001	71	view →
SKCM	OS	Median	All	0.395	0.251	<.001	61	view →
LUSC	DFS	Median	II,III,IV	0.277	0.518	<.001	59	view →
LAML	DFS	Quartile	All	0.734	0.470	.001	30	view →
MESO	OS	Quartile	IV	0.897	0.319	.006	26	view →
THYM	DFS	Tertile	II,III,IV	0.811	0.456	.006	23	view →
STAD	OS	Tertile	All	0.528	0.670	.010	15	view →
DLBC	OS	Median	All	1.000	0.482	.011	14	view →
ESCA	OS	Tertile	IV	0.247	0.922	.024	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

MIR100HG–KIRP (DFS)

Open the KIRP breakdown →